ロード中...
Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
BACKGROUND: The Response Evaluation Criteria in Solid Tumors (RECIST) for computed tomography (CT) is preoperatively used to evaluate therapeutic effects. However, it does not reflect the pathological treatment response (PTR) of pancreatic ductal adenocarcinoma (PDAC). The Positron Emission Tomograp...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300404/ https://ncbi.nlm.nih.gov/pubmed/32281301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3044 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|